Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Singapore medical journal ; : 188-190, 2016.
Article in English | WPRIM | ID: wpr-296443

ABSTRACT

<p><b>INTRODUCTION</b>Community-based exercise programmes have been shown to be effective in the Western world. However, there is a dearth of literature on their effectiveness in Asia. This pilot study aims to assess the effectiveness of the Asian community-based Health Wellness Programme (HWP) in Singapore. The HWP provides community cardiac rehabilitation services.</p><p><b>METHODS</b>A retrospective database analysis was conducted on cardiac rehabilitation patients who had completed the one-year wellness programme from 2010 to 2011. Patients were included in the programme if they had an underlying cardiac disease such as ischaemic heart disease and were deemed as stable by their cardiologist. Patients with New York Heart Association Class III or IV heart failure were excluded from this programme. Sociodemographic, anthropometric, clinical and laboratory data was recorded. Changes between the baseline and final measurements were analysed.</p><p><b>RESULTS</b>Complete data from a total of 136 patients was analysed. Improvements were noted in body fat percentage (change [Δ] -1.3%, p < 0.01), distance walked (Δ 9.7 m, p = 0.01), total cholesterol (Δ -7.8 mg/dL, p = 0.03), low-density lipoprotein (Δ -7.8 mg/dL, p = 0.03) and triglyceride (Δ -17.8 mg/dL, p < 0.01).</p><p><b>CONCLUSION</b>The low-to-moderate intensity HWP seems to be effective in a multiethnic community setting. To confirm the quality and effectiveness of such a programme in secondary cardiovascular prevention, more evidence from prospective controlled trials with suitable controls is needed.</p>


Subject(s)
Aged , Female , Humans , Male , Cardiac Rehabilitation , Methods , Ethnicity , Follow-Up Studies , Health Promotion , Heart Failure , Ethnology , Rehabilitation , Morbidity , Pilot Projects , Retrospective Studies , Singapore , Epidemiology
2.
Singapore medical journal ; : 393-400, 2015.
Article in English | WPRIM | ID: wpr-337122

ABSTRACT

<p><b>INTRODUCTION</b>As the effectiveness of intensive glycaemic control is unclear and recommended glycaemic targets are inconsistent, this study aimed to ascertain the prevalence of dysglycaemia among hospitalised patients with diabetes mellitus in an Asian population and evaluate the current standards of inpatient glycaemic control.</p><p><b>METHODS</b>A retrospective observational study was conducted at a secondary hospital. Point-of-care blood glucose (BG) values, demographic data, medical history, glycaemic therapy and clinical characteristics were recorded. Dysglycaemia prevalence was calculated as proportions of BG-monitored days with at least one reading exceeding the cut points of 8, 10 and 15 mmol/L for hyperglycaemia, and below the cut point of 4 mmol/L for hypoglycaemia.</p><p><b>RESULTS</b>Among the 288 patients recruited, hyperglycaemia was highly prevalent (90.3%, 81.3% and 47.6% for the respective cut points), while hypoglycaemia was the least prevalent (18.8%). Dysglycaemic patients were more likely than normoglycaemic patients to have poorer glycated haemoglobin (HbA1c) levels (8.4% ± 2.6% vs. 7.3% ± 1.9%; p = 0.002 for BG > 10 mmol/L) and longer lengths of stay (10.1 ± 8.2 days vs. 6.8 ± 4.7 days; p = 0.007 for BG < 4 mmol/L). Hyperglycaemia was more prevalent in patients on more intensive treatment regimens, such as basal-bolus combination therapy and the use of both insulin and oral hypoglycaemic agents (100.0% and 96.0%, respectively; p < 0.001 for BG > 10 mmol/L).</p><p><b>CONCLUSION</b>Inpatient glycaemic control is suboptimal. Factors (e.g. type of treatment regimen, discipline and baseline HbA1c) associated with greater prevalence of dysglycaemia should be given due consideration in patient management.</p>


Subject(s)
Aged , Female , Humans , Male , Middle Aged , Blood Glucose , Diabetes Mellitus , Drug Therapy , Hospitals , Hyperglycemia , Drug Therapy , Hypoglycemia , Drug Therapy , Hypoglycemic Agents , Therapeutic Uses , Inpatients , Insulin , Therapeutic Uses , Point-of-Care Systems , Prevalence , Retrospective Studies , Singapore , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL